TL;DR
The B2B software purchasing process is undergoing a severe trust and structural crisis as buyers aggressively adopt generative AI for initial research while simultaneously demanding human-led validation to de-risk purchases. To survive an accelerating enterprise consolidation wave, software vendors must optimize their digital footprints for AI-driven shortlists while preparing for heavily scrutinized, trial-driven procurement cycles.
The "Split-Brain" Enterprise Buying Journey
Enterprise procurement is expanding and bifurcating as buyers delegate analytical research to AI but refuse to close deals without intense human validation.
"The buyer journey is basically split-brain now — buyers want AI for the cold, factual evaluation, and they prefer sales reps for trust and validation. They’re delegating logic and craving connection at the exact same time." — enterprise-buying-journey-stages
This division matters because the introduction of generative AI features causes the typical buying group—which already averages 13 internal stakeholders and 9 external influencers—to double in size enterprise-buying-journey-stages. To win these highly scrutinized deals, vendors must pivot their sales teams from traditional persuasion to "value affirmation," proving the software's specific business outcomes to ease the anxiety of skeptical procurement teams buyers-use-ai-dont-trust-it
.
What to watch: Whether B2B sales organizations successfully transition their compensation and training models to support "verification" rather than standard product pitching.
The Rise of the Mandatory, High-Risk Trial
Hands-on product evaluation has transitioned from a sales luxury to a mandatory risk-reduction strategy that frequently results in "trial hopping."
"Only 36% of buyers plan to convert to a fully paid version with the same provider after a trial... 35% of buyers plan to convert with a different provider." — enterprise-buying-journey-stages
This trend is a critical bottleneck for founders, given that 60% of all business buyers—and 78% of those negotiating deals worth $10 million or more—now require a trial before committing capital enterprise-buying-journey-stages. Because nearly two-thirds of trialing buyers plan to either switch vendors or start a new trial with a competitor, founders cannot treat sandboxes as passive previews; they must actively guide onboarding and measure real-time value metrics to prevent churn enterprise-buying-journey-stages
.
What to watch: The emergence of automated trial-management platforms designed to lock in buyer data and prevent competitors from poaching trial-stage accounts.
The Chatbot Shortlist and the New Trust Substrate
B2B software discovery has compressed into a single chatbot-generated answer, forcing brands to optimize for machine-readability and peer-review citations.
"We're watching the third compression era of the buyer journey unfold in real time... AI chatbots are compressing it into a single answer. Buyers have moved from reference to inference." — aeo-axo-frameworks-2026
This shift is reshaping marketing budgets because 51% of B2B software buyers now begin their research with an AI chatbot rather than Google aeo-axo-frameworks-2026. To ensure their products are recommended during these highly influential searches, founders must secure verified customer reviews on platforms like G2, as 45% of buyers identify review site citations as the most confidence-inspiring signal in an AI-generated recommendation aeo-axo-frameworks-2026
.
What to watch: How rapidly startups reallocate traditional SEO and paid-ad budgets toward review acquisition campaigns and technical AXO optimization.
The Aggressive Pruning of the Enterprise Tech Stack
Enterprise IT leaders are rapidly consolidating their software footprints, creating a stark valuation divide between multi-product platforms and isolated point solutions.
"68% of tech leaders plan vendor consolidation in 2026, with the majority targeting a 20% reduction in their total number of providers." — platform-consolidation-2026
This consolidation wave has shrunk the average enterprise SaaS footprint from a peak of 130 applications in 2022 down to 106 platform-consolidation-2026. This environment severely penalizes single-feature startups, driving a wedge between premium multi-product platforms commanding multiples of 6x to 8x ARR and struggling point solutions trading at compressed multiples of 3x to 4x ARR platform-consolidation-2026
.
What to watch: A potential surge in private equity-backed "buy-and-build" vertical SaaS roll-ups designed to package niche tools into comprehensive, single-vendor platforms.
What surprised us
- The AI Search Tipping Point: The speed of the transition is remarkable; the share of B2B software buyers starting their research with an AI chatbot rather than Google nearly doubled in a single year, jumping from 29% in April 2025 to 51% in April 2026 aeo-axo-frameworks-2026
.
- The AI Accuracy Crisis: Despite relying heavily on AI chatbots for critical software shortlists, 64% of buyers report encountering inaccurate chatbot recommendations "often or very often," highlighting a massive gap between tool utility and output trust buyers-use-ai-dont-trust-it
.
- The High Rate of Trial Defection: It is startling that only 36% of buyers plan to convert to a paid contract with the same provider after a trial enterprise-buying-journey-stages
. This means nearly two-thirds of trials essentially serve as free education or data-gathering exercises for competitors.
- Resilient Spend Amid Vendor Cuts: While CIOs are aggressively pruning their vendor counts by up to 20%, total enterprise software spending is still projected to grow 14.7% in 2026 to exceed $1.4 trillion platform-consolidation-2026
. The money is not leaving the ecosystem; it is simply being concentrated into fewer, larger platform hands.
Open threads worth a vote
- [watch] Forrester State of Business Buying 2027 Publication — Monitor the publication of Forrester's annual State of Business Buying 2027 report. Track whether B2B buying groups continue to expand (currently 13 internal, 9 external, doubling for AI purchases), whether the trial adoption rate (currently 60%) increases, and if procurement's early-stage influence (currently 53%) continues to grow.